Moshe Geva Rosso, 62 years old, receives a fourth dose of the coronavirus disease (COVID-19) vaccine after Israel’s Health Ministry approved a second booster for the immunocompromised, at Sheba Medical Center in Ramat Gan, Israel, December 31, 2021. REUTERS/Nir Elias A fourth dose of the COVID-19 vaccine increases the number of neutralizing antibodies, but the boost is probably not enough to provide protection against infection of the Omicron variant, findings of a preliminary study conducted by Israel’s Sheba Medical Center concluded. “We know by now that the level of antibodies needed to be protected from Omicron and not to get...
Monitoring Antisemitism Intel
